Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and NovoLog

• Generic Name: letrozole / ribociclib
• Dosage Forms: kit
• Other Brand Names: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose

Letrozole lowers estrogen levels, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.

Ribociclib interferes with the growth and spread of cancer cells in the body.

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose are used together in combination to treat HR-positive, HER2-negative breast cancer in women.

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose is used when the cancer has spread to other parts of the body (metastatic).

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose are two different medicines that are packaged together. Letrozole tablets are yellow and ribociclib tablets are violet.

Kisqali Femara Co-Pack 600 mg-2.5 mg Dose may also be used for purposes not listed in this medication guide.

• Generic Name: insulin aspart
• Dosage Forms: n.a.
• Other Brand Names: NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch

NovoLog (insulin aspart)is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood.

NovoLog is used to improve blood sugar control in adults and children with diabetes mellitus.

This medicine is sometimes used together with a long-acting or intermediate-acting insulin.

NovoLog is used to treat type 2 diabetes in adults.

NovoLog is also used to treat type 1 diabetes in adults and children who are at least 2 years old.